News

Purdue-Discovered ‘Fluorescent Markers’ to Illuminate Cancer, Improve Outcomes, Receives FDA Fast Track as Phase 3 Clinical Trials Begin
February 08, 2020
Intraoperative molecular imaging used to illuminate and target non-small-cell lung cancer shows improved outcomes for 26% of patients in multi-institutional Phase 2 clinical trial. WEST LAFAYETTE, Ind.
Genentech Submits Supplemental Biologics License Application to the FDA for Tecentriq in Combination With Avastin for the Most Common Form of Liver Cancer
January 30, 2020
Application is being reviewed under FDA's Real-Time Oncology Review pilot program.
First-of-its-Kind Technology Lights Up Lung Cancer Cells, Helps Improve Patient Outcomes
January 28, 2020
Fluorescent imaging changes course of diagnosis and prognosis  NEW ORLEANS, Louisiana—A groundbreaking tumor-highlighting technology—OTL38—enhances the visualization of lung cancer tissue, providing surgeons with a significantly better chance of…
ASCO Interview With Drs Constantino Peña and Ripal Gandhi
December 11, 2019
Constantino Peña, MD, FSIR, and Ripal Gandhi, MD, FSIR, FSVM, recently spoke with The ASCO Post. Their conversation focused on how interventional oncology is considered the fourth pillar of cancer care and how future applications may include…
A Novel, Non-Invasive MRI-Based Functional Liver Imaging Score (FLIS) for Investigating Chronic Liver Disease
November 21, 2019
Vienna, 20 November 2019) An interdisciplinary MedUni Vienna team has shown that important  information about the stage and prognosis of chronic liver diseases can be gotten by functional magnetic resonance imaging (fMRI). Lying in a tube-like…
Imactis Secures First US Customer With UW Health Acquiring Cutting-Edge Navigation System to Facilitate Image-Guided Interventional Oncology Procedures
November 06, 2019
Imactis, a French medical device company specialized in computer-assisted interventional radiology, today announces that UW Health, the academic medical center and health system of the University of Wisconsin, is the first hospital in the United…
SD Mines Researchers Target, Kill Cancer Cells with Cold Plasma
October 31, 2019
 
CIO 2019 Offers Dramatic Learning Opportunities With “Case Saves and Complications”
October 12, 2019
Nine faculty members presented in a session entitled “Outside Your IO Comfort Zone: Learning from Our Saves and Complications”, sharing both catastrophic complication and miraculous save cases. 
VR Case Viewing
“First of Its Kind”: Cutting-Edge Virtual Reality Thyroid Ablation Case Presented at CIO 2019
October 12, 2019
Saturday, October 12, 2019 (Miami, FL): Today the Symposium on Clinical Interventional Oncology (CIO) experienced an educational first-in-technology presentation by Course Co-Director Ziv Haskal, MD, Professor/Fellowship Director, Interventional…
Dr Yolanda Bryce
Growth Areas in Interventional Oncology at CIO 2019
October 12, 2019
The Symposium on Clinical Interventional Oncology featured a morning session focusing on therapeutic areas that are positioned to grow.
Sarah White, MD, MS
Top Pearls for Liver Therapy Presented at CIO 2019
October 11, 2019
Friday, October 11, 2019 (Miami, FL) — Providing attendees with practical take-home tips for the treatment of liver cancer was the purpose of the final session on day one of the Symposium on Clinical Interventional Oncology (CIO).
Back to Top